The RNA therapy market presents opportunities in innovative RNA modalities, personalized medicine demand, and strategic ...

Key market opportunities in the RNA Therapy Clinical Trials sector include an increase in chronic and rare diseases, advancements in delivery technologies like lipid nanoparticles, robust venture ...

Researchers from Carnegie Mellon University have discovered a way to target RNA that could lead to new treatment options for ...

La Jolla Labs was founded to make modern RNA biology and advanced computational techniques directly useful to patients whose ...

Dr Mark Kris discusses the increasing precision of lung cancer therapies and the need for additional testing to find ...

Aperture Therapeutics is advancing APRTX-003, an RNA-based antisense therapy targeting MMP9, as a potential ALS treatment.

Osteoarthritis is a highly prevalent joint disease that leads to cartilage breakdown, pain and disability, yet there are ...

Nitin Joshi, PhD, and Jingjing Gao, PhD, of the Department of Anesthesiology at Mass General Brigham, are the co-senior ...

Researchers at Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine, have documented their use of a new RNA sequencing technology to uncover molecular ...

Pancreatic ductal adenocarcinoma (PDAC) is the most lethal form of pancreas cancer. It's also the most common form of the disease. Potential treatments typically target a key mutated oncogene called ...

Researchers from the Wilmer Eye Institute, Johns Hopkins Medicine Center for Nanomedicine—which designs nanotechnology-based ...

RNA Drugs: presented yesterday in Naples, at the research area of Naples of the CNR, in via Pietro Castellino, the results of ...